EpimAb Biotherapeutics is Biotechnology in China that focus on development services business. Founded in 2016. They cover business area such as Provider, biopharmaceutical research, unique technology and development service, novel bi-specific antibody therapeutic, bispecific molecule, antibody-like property, change pipeline, novel bispecific antibody therapeutic, immuno-oncology, high value, patient.
2016
( 8 years old in 2024 )
Development Services
-
6th Floor, Building 2, Jinchuang Building
702 Zhongke Road, Zhangjiang High-Tech Park
Shanghai, Shanghai 201204
China
Private
Providerbiopharmaceutical researchunique technology and development servicenovel bi-specific antibody therapeuticbispecific moleculeantibody-like propertychange pipelinenovel bispecific antibody therapeuticimmuno-oncologyhigh valuepatient
* We use standard office opening hours in near EpimAb Biotherapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
EpimAb Biotherapeutics is Biotechnology business from China that founded in 2016 (8 years old in 2024), EpimAb Biotherapeutics business is focusing on Development Services.
EpimAb Biotherapeutics headquarter office and corporate office address is located in 6th Floor, Building 2, Jinchuang Building 702 Zhongke Road, Zhangjiang High-Tech Park Shanghai, Shanghai 201204 China.
EpimAb Biotherapeutics was founded in China.
In 2024, EpimAb Biotherapeutics is currently focus on development services sector.
Above is snippet of Google Trends for "development services" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with EpimAb Biotherapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
